S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
BABA   169.13 (-4.37%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
BABA   169.13 (-4.37%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
Log in

BIOLASE Price Target & Analyst Ratings (NASDAQ:BIOL)

$0.80
-0.20 (-20.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$0.78
Now: $0.80
$1.04
50-Day Range
$0.75
MA: $0.95
$1.07
52-Week Range
$0.75
Now: $0.80
$2.87
Volume315,677 shs
Average Volume47,590 shs
Market Capitalization$17.56 million
P/E RatioN/A
Dividend YieldN/A
Beta2.25

Analyst Ratings

BIOLASE (NASDAQ:BIOL) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for BIOLASE in the last 12 months. Their average twelve-month price target is $2.50, suggesting that the stock has a possible upside of 212.50%. The high price target for BIOL is $3.00 and the low price target for BIOL is $2.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.673.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.50$2.50$2.00N/A
Price Target Upside: 212.50% upside85.19% upside29.03% upsideN/A

BIOLASE (NASDAQ:BIOL) Consensus Price Target History

BIOLASE (NASDAQ:BIOL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/12/2019Ascendiant Capital MarketsSet Price TargetBuy$3.00High
6/19/2019BenchmarkInitiated CoverageSpeculative Buy ➝ Speculative Buy$2.00High
4/30/2019Dougherty & CoReiterated RatingBuyHigh
3/7/2019Singular ResearchReiterated RatingBuyHigh
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel